Sinai Medical Center Cedars's Net Worth

$8.01 Million

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Sinai Medical Center Cedars?

Sinai Medical Center Cedars has an estimated net worth of $8.01 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., CAPRICOR THERAPEUTICS, INC., and SRKP 16 INC.

SEC CIK

Sinai Medical Center Cedars's CIK is 0001269910

Past Insider Trading and Trends

2021 was Sinai Medical Center Cedars's most active year for acquiring shares with 5 total transactions. Sinai Medical Center Cedars's most active month to acquire stocks was the month of February. 2021 was Sinai Medical Center Cedars's most active year for disposing of shares, totalling 5 transactions. Sinai Medical Center Cedars's most active month to dispose stocks was the month of February. 2017 saw Sinai Medical Center Cedars paying a total of $3,549,999.10 for 1,145,161 shares, this is the most they've acquired in one year. In 2021 Sinai Medical Center Cedars cashed out on 44,160,081 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prometheus Biosciences, Inc. No price found

Investor

Sinai Medical Center Cedars owns 5,008,508 units of Common Stock. In the year 2021 Sinai Medical Center Cedars filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+745.32%
4.42M
—
—
5.01M
Mar 16
Form 3
—
0
—
—
0
No matching records found

CAPRICOR THERAPEUTICS, INC. (CAPR) Snapshot price: $4.09

Investor

Sinai Medical Center Cedars owns 4,049,959 units of Common Stock which is worth $16,564,332.31. In the year 2014 Sinai Medical Center Cedars acquired a total of 2,725,873 shares in CAPRICOR THERAPEUTICS, INC. at a cost of $8,549,994.06.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+39.42%
1.15M
$3.10
$3,549,999.10
4.05M
May 9
Form 4
+12.05%
312.5K
$3.20
$1,000,000.00
2.9M
Sep 21
Form 4
+19.15%
416.67K
$2.40
$999,998.40
2.59M
Mar 16
Form 4
+64.31%
851.55K
$3.52
$2,999,996.56
2.18M
Jan 21
Form 3
—
0
—
—
0
No matching records found

SRKP 16 INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found